EUCRW
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
EUCRW
Delisted
EUCRW was delisted on the 26th of April, 2023.
26 hedge funds and large institutions have $1.09M invested in Eucrates Biomedical Acquisition Corp. Warrant in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
3
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$659K
Top Buyers
Top Sellers
1 |
SCM
1
Suvretta Capital Management
New York
|
$0 |
2 |
WRBC
2
W.R. Berkley Corp
Greenwich,
Connecticut
|
$0 |
3 |
CAC
3
Cowen and Company
New York
|
$8K |
4 |
4
Goldman Sachs
New York
|
$5K |
5 |
5
BlackRock
New York
|
$9K |